Feasibility and Cost Analysis of PBSC Mobilization Using Pegfilgrastim in Hematologic Malignancies

NCT00689884 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Lack of enrollment.

Conditions

Hematologic Malignancies

Interventions

DRUG: Pegfilgrastim

Sponsor

Dartmouth-Hitchcock Medical Center